TreeWAS – Variant ID: rs3815003

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
S02.20 Fracture of nasal bones (closed)	0.022	0.978	0.000
Z75.1 Person awaiting admission to adequate facility elsewhere	0.000	0.987	0.013
Z03.5 Observation for other suspected cardiovascular diseases	0.000	0.988	0.012
Y40.1 Cefalosporins and other -lactam antibiotics	0.012	0.988	0.000
Y40.0 Penicillins	0.011	0.989	0.000
Y40 Systemic antibiotics	0.010	0.990	0.000
S02.2 Fracture of nasal bones	0.010	0.990	0.000
D12.6 Colon, unspecified	0.010	0.990	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.009	0.991	0.000
M00.96 Pyogenic arthritis, unspecified (Lower leg)	0.009	0.991	0.000
M00.9 Pyogenic arthritis, unspecified	0.009	0.991	0.000
Y40.8 Other systemic antibiotics	0.009	0.991	0.000
M00.94 Pyogenic arthritis, unspecified (Hand)	0.008	0.992	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.008	0.992	0.000
M00.95 Pyogenic arthritis, unspecified (Pelvic region and thigh)	0.008	0.992	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.008	0.992	0.000
M00.93 Pyogenic arthritis, unspecified (Forearm)	0.008	0.992	0.000
Y40.7 Antifungal antibiotics, systemically used	0.007	0.992	0.000
Y40.4 Tetracyclines	0.007	0.992	0.000
Y40.2 Chloramphenicol group	0.007	0.992	0.000
L03.0 Cellulitis of finger and toe	0.007	0.993	0.000
M00.91 Pyogenic arthritis, unspecified (Shoulder region)	0.007	0.993	0.000
Y40.6 Rifamycins	0.007	0.993	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.007	0.993	0.000
Y53.4 Other laxatives	0.007	0.993	0.000
Y45.2 Propionic acid derivatives	0.007	0.993	0.000
Y40.3 Macrolides	0.007	0.993	0.000
M00.90 Pyogenic arthritis, unspecified (Multiple sites)	0.007	0.993	0.000
Y40.5 Aminoglycosides	0.007	0.993	0.000
M00.97 Pyogenic arthritis, unspecified (Ankle and foot)	0.007	0.993	0.000
S02.21 Fracture of nasal bones (open)	0.007	0.993	0.000
Y45.5 4-Aminophenol derivatives	0.007	0.993	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.007	0.993	0.000
M00.99 Pyogenic arthritis, unspecified (Site unspecified)	0.007	0.993	0.000
M00.98 Pyogenic arthritis, unspecified (Other)	0.007	0.993	0.000
M00.92 Pyogenic arthritis, unspecified (Upper arm)	0.007	0.993	0.000
Y53.2 Stimulant laxatives	0.006	0.993	0.000
Z75 Problems related to medical facilities and other health care	0.000	0.993	0.007
Y58 Bacterial vaccines	0.006	0.994	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.006	0.994	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.006	0.994	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.006	0.994	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.006	0.994	0.000
Y54.7 Agents affecting calcification	0.006	0.994	0.000
Y59 Other and unspecified vaccines and biological substances	0.006	0.994	0.000
M00 Pyogenic arthritis	0.006	0.994	0.000
Y45.4 Antirheumatics	0.006	0.994	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.006	0.994	0.000
Y53.7 Emetics	0.006	0.994	0.000
Y53.6 Antidiarrhoeal drugs	0.006	0.994	0.000
Y53.5 Digestants	0.006	0.994	0.000
Y53.3 Saline and osmotic laxatives	0.006	0.994	0.000
Y53.0 Histamine H2-receptor antagonists	0.006	0.994	0.000
Z75.4 Unavailability and inaccessibility of other helping agencies	0.000	0.994	0.006
Y58.0 BCG vaccine	0.006	0.994	0.000
Z75.5 Holiday relief care	0.000	0.994	0.006
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.005	0.994	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.005	0.994	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
Y41.0 Sulphonamides	0.005	0.995	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.005	0.995	0.000
Y44 Agents primarily affecting blood constituents	0.005	0.995	0.000
Y54.0 Mineralocorticoids	0.005	0.995	0.000
Y47.1 Benzodiazepines	0.005	0.995	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.005	0.995	0.000
Y59.3 Immunoglobulin	0.005	0.995	0.000
Z75.9 Unspecified problem related to medical facilities and other health care	0.000	0.995	0.005
Z75.0 Medical services not available in home	0.000	0.995	0.005
Y52 Agents primarily affecting the cardiovascular system	0.005	0.995	0.000
Y43.1 Antineoplastic antimetabolites	0.005	0.995	0.000
Y45.1 Salicylates	0.005	0.995	0.000
N88.2 Stricture and stenosis of cervix uteri	0.005	0.995	0.000
Y58.9 Other and unspecified bacterial vaccines	0.005	0.995	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.005	0.995	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.005	0.995	0.000
Y58.5 Diphtheria vaccine	0.005	0.995	0.000
Y58.4 Tetanus vaccine	0.005	0.995	0.000
Y58.3 Plague vaccine	0.005	0.995	0.000
Y58.2 Cholera vaccine	0.005	0.995	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.005	0.995	0.000
Y48 Anaesthetics and therapeutic gases	0.005	0.995	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
Y43 Primarily systemic agents	0.005	0.995	0.000
Y54.9 Mineral salts, not elsewhere classified	0.005	0.995	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.005	0.995	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.005	0.995	0.000
M00.8 Arthritis and polyarthritis due to other specified bacterial agents	0.005	0.995	0.000
Y46.6 Other and unspecified antiepileptics	0.005	0.995	0.000
Y54.4 Loop [high-ceiling] diuretics	0.005	0.995	0.000
Y45.0 Opioids and related analgesics	0.005	0.995	0.000
Z75.8 Other problems related to medical facilities and other health care	0.000	0.995	0.005
Y54.8 Agents affecting uric acid metabolism	0.005	0.995	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.995	0.000
Y41.4 Anthelminthics	0.004	0.995	0.000
Y41.3 Other antiprotozoal drugs	0.004	0.995	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.995	0.000
Y41.1 Antimycobacterial drugs	0.004	0.995	0.000
Y54.5 Other diuretics	0.005	0.995	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.004	0.995	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.004	0.995	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.004	0.995	0.000
Y47.4 Bromine compounds	0.004	0.995	0.000
Y47.3 Paraldehyde	0.004	0.995	0.000
Y47.2 Chloral derivatives	0.004	0.995	0.000
Y47.0 Barbiturates, not elsewhere classified	0.004	0.995	0.000
M00.0 Staphylococcal arthritis and polyarthritis	0.004	0.995	0.000
T31.0 Burns involving less than 10% of body surface	0.005	0.995	0.000
Y59.9 Vaccine or biological substance, unspecified	0.004	0.995	0.000
Y59.8 Other specified vaccines and biological substances	0.004	0.995	0.000
Y59.2 Protozoal vaccines	0.004	0.995	0.000
Y59.1 Rickettsial vaccines	0.004	0.995	0.000
Y59.0 Viral vaccines	0.004	0.995	0.000
Y41.5 Antiviral drugs	0.004	0.995	0.000
M00.2 Other streptococcal arthritis and polyarthritis	0.004	0.995	0.000
M00.1 Pneumococcal arthritis and polyarthritis	0.004	0.995	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
Z75.2 Other waiting period for investigation and treatment	0.000	0.996	0.004
Y54.3 Benzothiadiazine derivatives	0.004	0.996	0.000
Y45.8 Other analgesics and antipyretics	0.004	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.004	0.996	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
Z75.3 Unavailability and inaccessibility of health-care facilities	0.000	0.996	0.004
Y50.9 Central nervous system stimulant, unspecified	0.004	0.996	0.000
Y50.8 Other central nervous system stimulants	0.004	0.996	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.004	0.996	0.000
Y50.1 Opioid receptor antagonists	0.004	0.996	0.000
Y50.0 Analeptics	0.004	0.996	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
Y55.5 Anticommon cold drugs	0.004	0.996	0.000
Y55.4 Expectorants	0.004	0.996	0.000
Y55.3 Antitussives	0.004	0.996	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
Y55.0 Oxytocic drugs	0.004	0.996	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.004	0.996	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
Y51.0 Anticholinesterase agents	0.004	0.996	0.000
Y48.4 Anaesthetic, unspecified	0.004	0.996	0.000
Y46.7 Anti-Parkinsonism drugs	0.004	0.996	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
Y46.8 Antispasticity drugs	0.004	0.996	0.000
Y46.5 Valproic acid	0.004	0.996	0.000
Y46.3 Deoxybarbiturates	0.004	0.996	0.000
Y46.1 Oxazolidinediones	0.004	0.996	0.000
Y46.0 Succinimides	0.004	0.996	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.004	0.996	0.000
Y44.7 Plasma substitutes	0.004	0.996	0.000
Y44.6 Natural blood and blood products	0.004	0.996	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.004	0.996	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.004	0.996	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.004	0.996	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y43.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
M00.86 Arthritis and polyarthritis due to other specified bacterial agents (Lower leg)	0.004	0.996	0.000
Y57 Other and unspecified drugs and medicaments	0.004	0.996	0.000
Y44.5 Thrombolytic drugs	0.004	0.996	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
Y52.7 Peripheral vasodilators	0.004	0.996	0.000
K22.8 Other specified diseases of oesophagus	0.000	0.996	0.004
Y46.2 Hydantoin derivatives	0.004	0.996	0.000
O04.4 Incomplete, without complication	0.000	0.996	0.004
Y48.5 Therapeutic gases	0.003	0.996	0.000
Y48.1 Parenteral anaesthetics	0.003	0.996	0.000
Y48.0 Inhaled anaesthetics	0.003	0.996	0.000
Y43.9 Primarily systemic agent, unspecified	0.004	0.996	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.004	0.996	0.000
Y43.6 Enzymes, not elsewhere classified	0.004	0.996	0.000
Y43.5 Acidifying and alkalising agents	0.004	0.996	0.000
Y43.2 Antineoplastic natural products	0.004	0.996	0.000
O75.2 Pyrexia during labour, not elsewhere classified	0.004	0.996	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.000	0.996	0.004
M00.89 Arthritis and polyarthritis due to other specified bacterial agents (Site unspecified)	0.003	0.996	0.000
M00.88 Arthritis and polyarthritis due to other specified bacterial agents (Other)	0.003	0.996	0.000
M00.87 Arthritis and polyarthritis due to other specified bacterial agents (Ankle and foot)	0.003	0.996	0.000
M00.85 Arthritis and polyarthritis due to other specified bacterial agents (Pelvic region and thigh)	0.003	0.996	0.000
M00.84 Arthritis and polyarthritis due to other specified bacterial agents (Hand)	0.003	0.996	0.000
M00.83 Arthritis and polyarthritis due to other specified bacterial agents (Forearm)	0.003	0.996	0.000
M00.82 Arthritis and polyarthritis due to other specified bacterial agents (Upper arm)	0.003	0.996	0.000
M00.81 Arthritis and polyarthritis due to other specified bacterial agents (Shoulder region)	0.003	0.996	0.000
M00.80 Arthritis and polyarthritis due to other specified bacterial agents (Multiple sites)	0.003	0.996	0.000
Y44.2 Anticoagulants	0.004	0.996	0.000
Y48.2 Other and unspecified general anaesthetics	0.003	0.996	0.000
M00.06 Staphylococcal arthritis and polyarthritis (Lower leg)	0.003	0.996	0.000
Y40.9 Systemic antibiotic, unspecified	0.003	0.996	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
M00.09 Staphylococcal arthritis and polyarthritis (Site unspecified)	0.003	0.996	0.000
M00.08 Staphylococcal arthritis and polyarthritis (Other)	0.003	0.996	0.000
M00.07 Staphylococcal arthritis and polyarthritis (Ankle and foot)	0.003	0.996	0.000
M00.05 Staphylococcal arthritis and polyarthritis (Pelvic region and thigh)	0.003	0.996	0.000
M00.04 Staphylococcal arthritis and polyarthritis (Hand)	0.003	0.996	0.000
M00.03 Staphylococcal arthritis and polyarthritis (Forearm)	0.003	0.996	0.000
M00.02 Staphylococcal arthritis and polyarthritis (Upper arm)	0.003	0.996	0.000
M00.01 Staphylococcal arthritis and polyarthritis (Shoulder region)	0.003	0.996	0.000
M00.00 Staphylococcal arthritis and polyarthritis (Multiple sites)	0.003	0.996	0.000
M00.19 Pneumococcal arthritis and polyarthritis (Site unspecified)	0.003	0.996	0.000
M00.18 Pneumococcal arthritis and polyarthritis (Other)	0.003	0.996	0.000
M00.17 Pneumococcal arthritis and polyarthritis (Ankle and foot)	0.003	0.996	0.000
M00.16 Pneumococcal arthritis and polyarthritis (Lower leg)	0.003	0.996	0.000
M00.15 Pneumococcal arthritis and polyarthritis (Pelvic region and thigh)	0.003	0.996	0.000
M00.14 Pneumococcal arthritis and polyarthritis (Hand)	0.003	0.996	0.000
M00.13 Pneumococcal arthritis and polyarthritis (Forearm)	0.003	0.996	0.000
M00.12 Pneumococcal arthritis and polyarthritis (Upper arm)	0.003	0.996	0.000
M00.11 Pneumococcal arthritis and polyarthritis (Shoulder region)	0.003	0.996	0.000
M00.10 Pneumococcal arthritis and polyarthritis (Multiple sites)	0.003	0.996	0.000
M00.29 Other streptococcal arthritis and polyarthritis (Site unspecified)	0.003	0.996	0.000
M00.28 Other streptococcal arthritis and polyarthritis (Other)	0.003	0.996	0.000
M00.27 Other streptococcal arthritis and polyarthritis (Ankle and foot)	0.003	0.996	0.000
M00.26 Other streptococcal arthritis and polyarthritis (Lower leg)	0.003	0.996	0.000
M00.25 Other streptococcal arthritis and polyarthritis (Pelvic region and thigh)	0.003	0.996	0.000
M00.24 Other streptococcal arthritis and polyarthritis (Hand)	0.003	0.996	0.000
M00.23 Other streptococcal arthritis and polyarthritis (Forearm)	0.003	0.996	0.000
M00.22 Other streptococcal arthritis and polyarthritis (Upper arm)	0.003	0.996	0.000
M00.21 Other streptococcal arthritis and polyarthritis (Shoulder region)	0.003	0.996	0.000
M00.20 Other streptococcal arthritis and polyarthritis (Multiple sites)	0.003	0.996	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.996	0.000
S82.40 Fracture of fibula alone (closed)	0.003	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.003	0.997	0.000
Y56.8 Other topical agents	0.003	0.997	0.000
Y56.7 Dental drugs, topically applied	0.003	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
Y56.2 Local astringents and local detergents	0.003	0.997	0.000
Y56.1 Antipruritics	0.003	0.997	0.000
S02 Fracture of skull and facial bones	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
Y57.8 Other drugs and medicaments	0.003	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.000	0.997	0.003
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
S02.0 Fracture of vault of skull	0.003	0.997	0.000
R10.2 Pelvic and perineal pain	0.003	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
M00-M03 Infectious arthropathies	0.003	0.997	0.000
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
Y46.4 Iminostilbenes	0.003	0.997	0.000
Y57.6 Other diagnostic agents	0.003	0.997	0.000
S02.00 Fracture of vault of skull (closed)	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
H10.9 Conjunctivitis, unspecified	0.003	0.997	0.000
S02.9 Fracture of skull and facial bones, part unspecified	0.003	0.997	0.000
S02.1 Fracture of base of skull	0.003	0.997	0.000
M02 Reactive arthropathies	0.003	0.997	0.000
S02.5 Fracture of tooth	0.003	0.997	0.000
I98.2 Oesophageal varices in diseases classified elsewhere	0.000	0.997	0.003
S02.7 Multiple fractures involving skull and facial bones	0.003	0.997	0.000
Y43.4 Immunosuppressive agents	0.003	0.997	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.997	0.000
C43.5 Malignant melanoma of trunk	0.000	0.997	0.003
O04 Medical abortion	0.000	0.997	0.003
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
Z74.0 Reduced mobility	0.003	0.997	0.000
M54.94 Dorsalgia, unspecified (Thoracic region)	0.002	0.997	0.000
T88.7 Unspecified adverse effect of drug or medicament	0.002	0.997	0.000
S02.01 Fracture of vault of skull (open)	0.002	0.998	0.000
S02.8 Fractures of other skull and facial bones	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.001
M03 Postinfective and reactive arthropathies in diseases classified elsewhere	0.002	0.998	0.000
M01 Direct infections of joint in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
S02.3 Fracture of orbital floor	0.002	0.998	0.000
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.000	0.998	0.002
T31 Burns classified according to extent of body surface involved	0.002	0.998	0.000
M02.3 Reiter's disease	0.002	0.998	0.000
O04.1 Incomplete, complicated by delayed or excessive haemorrhage	0.000	0.998	0.002
Y42.4 Oral contraceptives	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
C77.9 Lymph node, unspecified	0.000	0.998	0.002
E16.2 Hypoglycaemia, unspecified	0.000	0.998	0.002
Y42.2 Antithyroid drugs	0.002	0.998	0.000
M02.9 Reactive arthopathy, unspecified	0.002	0.998	0.000
O04.9 Complete or unspecified, without complication	0.000	0.998	0.002
M45.X9 Ankylosing spondylitis (Site unspecified)	0.000	0.998	0.002
S02.6 Fracture of mandible	0.002	0.998	0.000
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.001
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
S02.11 Fracture of base of skull (open)	0.002	0.998	0.000
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.002	0.998	0.000
S02.51 Fracture of tooth (open)	0.002	0.998	0.000
M02.8 Other reactive arthropathies	0.002	0.998	0.000
M02.2 Postimmunisation arthropathy	0.002	0.998	0.000
M02.1 Postdysenteric arthropathy	0.002	0.998	0.000
M02.0 Arthropathy following intestinal bypass	0.002	0.998	0.000
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.000	0.998	0.002
H10 Conjunctivitis	0.002	0.998	0.000
M02.39 Reiter's disease (Site unspecified)	0.002	0.998	0.000
S02.10 Fracture of base of skull (closed)	0.002	0.998	0.000
S02.50 Fracture of tooth (closed)	0.002	0.998	0.000
S02.71 Multiple fractures involving skull and facial bones (open)	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
O04.8 Complete or unspecified, with other and unspecified complications	0.000	0.998	0.002
O04.7 Complete or unspecified, complicated by embolism	0.000	0.998	0.002
O04.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.000	0.998	0.002
O04.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.000	0.998	0.002
O04.3 Incomplete, with other and unspecified complications	0.000	0.998	0.002
O04.2 Incomplete, complicated by embolism	0.000	0.998	0.002
O04.0 Incomplete, complicated by genital tract and pelvic infection	0.000	0.998	0.002
S02.4 Fracture of malar and maxillary bones	0.002	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Z63.7 Other stressful life events affecting family and household	0.002	0.998	0.000
S02.70 Multiple fractures involving skull and facial bones (closed)	0.002	0.998	0.000
Y42.5 Other oestrogens and progestogens	0.002	0.998	0.000
M02.96 Reactive arthropathy, unspecified (Lower leg)	0.002	0.998	0.000
L27.0 Generalised skin eruption due to drugs and medicaments	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
S02.81 Fractures of other skull and facial bones (open)	0.002	0.998	0.000
M01.8 Arthritis in other infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
M01.6 Arthritis in mycoses	0.002	0.998	0.000
M01.5 Arthritis in other viral diseases classified elsewhere	0.002	0.998	0.000
M01.4 Rubella arthritis	0.002	0.998	0.000
M01.3 Arthritis in other bacterial diseases classified elsewhere	0.002	0.998	0.000
M01.2 Arthritis in Lyme disease	0.002	0.998	0.000
M01.1 Tuberculous arthritis	0.002	0.998	0.000
M01.0 Meningococcal arthritis	0.002	0.998	0.000
M03.6 Reactive arthropathy in other diseases classified elsewhere	0.002	0.998	0.000
M03.2 Other postinfectious arthropathies in diseases classified elsewhere	0.002	0.998	0.000
M03.1 Postinfective arthropathy in syphilis	0.002	0.998	0.000
M03.0 Postmeningococcal arthritis	0.002	0.998	0.000
S02.31 Fracture of orbital floor (open)	0.002	0.998	0.000
K75.0 Abscess of liver	0.002	0.998	0.000
T31.9 Burns involving 90% or more of body surface	0.002	0.998	0.000
T31.8 Burns involving 80-89% of body surface	0.002	0.998	0.000
T31.7 Burns involving 70-79% of body surface	0.002	0.998	0.000
T31.6 Burns involving 60-69% of body surface	0.002	0.998	0.000
T31.5 Burns involving 50-59% of body surface	0.002	0.998	0.000
T31.4 Burns involving 40-49% of body surface	0.002	0.998	0.000
T31.3 Burns involving 30-39% of body surface	0.002	0.998	0.000
T31.2 Burns involving 20-29% of body surface	0.002	0.998	0.000
M02.38 Reiter's disease (Other)	0.002	0.998	0.000
M02.37 Reiter's disease (Ankle and foot)	0.002	0.998	0.000
M02.36 Reiter's disease (Lower leg)	0.002	0.998	0.000
M02.35 Reiter's disease (Pelvic region and thigh)	0.002	0.998	0.000
M02.34 Reiter's disease (Hand)	0.002	0.998	0.000
M02.33 Reiter's disease (Forearm)	0.002	0.998	0.000
M02.32 Reiter's disease (Upper arm)	0.002	0.998	0.000
M02.31 Reiter's disease (Shoulder region)	0.002	0.998	0.000
M02.30 Reiter's disease (Multiple sites)	0.002	0.998	0.000
H10.8 Other conjunctivitis	0.002	0.998	0.000
H10.0 Mucopurulent conjunctivitis	0.002	0.998	0.000
M02.99 Reactive arthropathy, unspecified (Site unspecified)	0.002	0.998	0.000
M02.98 Reactive arthropathy, unspecified (Other)	0.002	0.998	0.000
M02.97 Reactive arthropathy, unspecified (Ankle and foot)	0.002	0.998	0.000
M02.95 Reactive arthropathy, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M02.94 Reactive arthropathy, unspecified (Hand)	0.002	0.998	0.000
M02.93 Reactive arthropathy, unspecified (Forearm)	0.002	0.998	0.000
M02.92 Reactive arthropathy, unspecified (Upper arm)	0.002	0.998	0.000
M02.91 Reactive arthropathy, unspecified (Shoulder region)	0.002	0.998	0.000
M79.84 Other specified soft tissue disorders (Hand)	0.002	0.998	0.000
S02.41 Fracture of malar and maxillary bones (open)	0.002	0.998	0.000
H52.3 Anisometropia and aniseikonia	0.002	0.998	0.000
S02.61 Fracture of mandible (open)	0.002	0.998	0.000
H35.4 Peripheral retinal degeneration	0.002	0.998	0.000
M02.90 Reactive arthropathy, unspecified (Multiple sites)	0.002	0.998	0.000
R23.4 Changes in skin texture	0.000	0.998	0.002
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
H10.4 Chronic conjunctivitis	0.002	0.998	0.000
M02.09 Arthropathy following intestinal bypass (Site unspecified)	0.002	0.998	0.000
M02.08 Arthropathy following intestinal bypass (Other)	0.002	0.998	0.000
M02.07 Arthropathy following intestinal bypass (Ankle and foot)	0.002	0.998	0.000
M02.06 Arthropathy following intestinal bypass (Lower leg)	0.002	0.998	0.000
M02.05 Arthropathy following intestinal bypass (Pelvic region and thigh)	0.002	0.998	0.000
M02.04 Arthropathy following intestinal bypass (Hand)	0.002	0.998	0.000
M02.03 Arthropathy following intestinal bypass (Forearm)	0.002	0.998	0.000
M02.02 Arthropathy following intestinal bypass (Upper arm)	0.002	0.998	0.000
M02.01 Arthropathy following intestinal bypass (Shoulder region)	0.002	0.998	0.000
M02.00 Arthropathy following intestinal bypass (Multiple sites)	0.002	0.998	0.000
M02.19 Postdysenteric arthropathy (Site unspecified)	0.002	0.998	0.000
M02.18 Postdysenteric arthropathy (Other)	0.002	0.998	0.000
M02.17 Postdysenteric arthropathy (Ankle and foot)	0.002	0.998	0.000
M02.16 Postdysenteric arthropathy (Lower leg)	0.002	0.998	0.000
M02.15 Postdysenteric arthropathy (Pelvic region and thigh)	0.002	0.998	0.000
M02.14 Postdysenteric arthropathy (Hand)	0.002	0.998	0.000
M02.13 Postdysenteric arthropathy (Forearm)	0.002	0.998	0.000
M02.12 Postdysenteric arthropathy (Upper arm)	0.002	0.998	0.000
M02.11 Postdysenteric arthropathy (Shoulder region)	0.002	0.998	0.000
M02.10 Postdysenteric arthropathy (Multiple sites)	0.002	0.998	0.000
M02.29 Postimmunization arthropathy (Site unspecified)	0.002	0.998	0.000
M02.28 Postimmunization arthropathy (Other)	0.002	0.998	0.000
M02.27 Postimmunization arthropathy (Ankle and foot)	0.002	0.998	0.000
M02.26 Postimmunization arthropathy (Lower leg)	0.002	0.998	0.000
M02.25 Postimmunization arthropathy (Pelvic region and thigh)	0.002	0.998	0.000
M02.24 Postimmunization arthropathy (Hand)	0.002	0.998	0.000
M02.23 Postimmunization arthropathy (Forearm)	0.002	0.998	0.000
M02.22 Postimmunization arthropathy (Upper arm)	0.002	0.998	0.000
M02.21 Postimmunization arthropathy (Shoulder region)	0.002	0.998	0.000
M02.20 Postimmunization arthropathy (Multiple sites)	0.002	0.998	0.000
M02.89 Other reactive arthropathies (Site unspecified)	0.002	0.998	0.000
M02.88 Other reactive arthropathies (Other)	0.002	0.998	0.000
M02.87 Other reactive arthropathies (Ankle and foot)	0.002	0.998	0.000
M02.86 Other reactive arthropathies (Lower leg)	0.002	0.998	0.000
M02.85 Other reactive arthropathies (Pelvic region and thigh)	0.002	0.998	0.000
M02.84 Other reactive arthropathies (Hand)	0.002	0.998	0.000
M02.83 Other reactive arthropathies (Forearm)	0.002	0.998	0.000
M02.82 Other reactive arthropathies (Upper arm)	0.002	0.998	0.000
M02.81 Other reactive arthropathies (Shoulder region)	0.002	0.998	0.000
M02.80 Other reactive arthropathies (Multiple sites)	0.002	0.998	0.000
H10.5 Blepharoconjunctivitis	0.002	0.998	0.000
H10.2 Other acute conjunctivitis	0.002	0.998	0.000
H10.1 Acute atopic conjunctivitis	0.002	0.998	0.000
T31.1 Burns involving 10-19% of body surface	0.002	0.998	0.000
Z50.5 Speech therapy	0.000	0.998	0.002
M79.09 Rheumatism, unspecified (Site unspecified)	0.000	0.998	0.002
H35.2 Other proliferative retinopathy	0.002	0.998	0.000
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.002	0.998	0.000
S52.10 Fracture of upper end of radius (closed)	0.000	0.998	0.002
H10.3 Acute conjunctivitis, unspecified	0.002	0.998	0.000
H90.3 Sensorineural hearing loss, bilateral	0.002	0.998	0.000
M06.34 Rheumatoid nodule (Hand)	0.002	0.998	0.000
M79.00 Rheumatism, unspecified (Multiple sites)	0.000	0.998	0.002
S02.80 Fractures of other skull and facial bones (closed)	0.002	0.998	0.000
G12.2 Motor neuron disease	0.002	0.998	0.000
M01.09 Meningococcal arthritis (Site unspecified)	0.001	0.998	0.000
M01.08 Meningococcal arthritis (Other)	0.001	0.998	0.000
M01.07 Meningococcal arthritis (Ankle and foot)	0.001	0.998	0.000
M01.06 Meningococcal arthritis (Lower leg)	0.001	0.998	0.000
M01.05 Meningococcal arthritis (Pelvic region and thigh)	0.001	0.998	0.000
M01.04 Meningococcal arthritis (Hand)	0.001	0.998	0.000
M01.03 Meningococcal arthritis (Forearm)	0.001	0.998	0.000
M01.02 Meningococcal arthritis (Upper arm)	0.001	0.998	0.000
M01.01 Meningococcal arthritis (Shoulder region)	0.001	0.998	0.000
M01.00 Meningococcal arthritis (Multiple sites)	0.001	0.998	0.000
M01.19 Tuberculous arthritis (Site unspecified)	0.001	0.998	0.000
M01.18 Tuberculous arthritis (Other)	0.001	0.998	0.000
M01.17 Tuberculous arthritis (Ankle and foot)	0.001	0.998	0.000
M01.16 Tuberculous arthritis (Lower leg)	0.001	0.998	0.000
M01.15 Tuberculous arthritis (Pelvic region and thigh)	0.001	0.998	0.000
M01.14 Tuberculous arthritis (Hand)	0.001	0.998	0.000
M01.13 Tuberculous arthritis (Forearm)	0.001	0.998	0.000
M01.12 Tuberculous arthritis (Upper arm)	0.001	0.998	0.000
M01.11 Tuberculous arthritis (Shoulder region)	0.001	0.998	0.000
M01.10 Tuberculous arthritis (Multiple sites)	0.001	0.998	0.000
M01.29 Arthritis in Lyme disease (Site unspecified)	0.001	0.998	0.000
M01.28 Arthritis in Lyme disease (Other)	0.001	0.998	0.000
M01.27 Arthritis in Lyme disease (Ankle and foot)	0.001	0.998	0.000
M01.26 Arthritis in Lyme disease (Lower leg)	0.001	0.998	0.000
M01.25 Arthritis in Lyme disease (Pelvic region and thigh)	0.001	0.998	0.000
M01.24 Arthritis in Lyme disease (Hand)	0.001	0.998	0.000
M01.23 Arthritis in Lyme disease (Forearm)	0.001	0.998	0.000
M01.22 Arthritis in Lyme disease (Upper arm)	0.001	0.998	0.000
M01.21 Arthritis in Lyme disease (Shoulder region)	0.001	0.998	0.000
M01.20 Arthritis in Lyme disease (Multiple sites)	0.001	0.998	0.000
M01.39 Arthritis in other bacterial diseases classified elsewhere (Site unspecified)	0.001	0.998	0.000
M01.38 Arthritis in other bacterial diseases classified elsewhere (Other)	0.001	0.998	0.000
M01.37 Arthritis in other bacterial diseases classified elsewhere (Ankle and foot)	0.001	0.998	0.000
M01.36 Arthritis in other bacterial diseases classified elsewhere (Lower leg)	0.001	0.998	0.000
M01.35 Arthritis in other bacterial diseases classified elsewhere (Pelvic region and thigh)	0.001	0.998	0.000
M01.34 Arthritis in other bacterial diseases classified elsewhere (Hand)	0.001	0.998	0.000
M01.33 Arthritis in other bacterial diseases classified elsewhere (Forearm)	0.001	0.998	0.000
M01.32 Arthritis in other bacterial diseases classified elsewhere (Upper arm)	0.001	0.998	0.000
M01.31 Arthritis in other bacterial diseases classified elsewhere (Shoulder region)	0.001	0.998	0.000
M01.30 Arthritis in other bacterial diseases classified elsewhere (Multiple sites)	0.001	0.998	0.000
M01.49 Rubella arthritis (Site unspecified)	0.001	0.998	0.000
M01.48 Rubella arthritis (Other)	0.001	0.998	0.000
M01.47 Rubella arthritis (Ankle and foot)	0.001	0.998	0.000
M01.46 Rubella arthritis (Lower leg)	0.001	0.998	0.000
M01.45 Rubella arthritis (Pelvic region and thigh)	0.001	0.998	0.000
M01.44 Rubella arthritis (Hand)	0.001	0.998	0.000
M01.43 Rubella arthritis (Forearm)	0.001	0.998	0.000
M01.42 Rubella arthritis (Upper arm)	0.001	0.998	0.000
M01.41 Rubella arthritis (Shoulder region)	0.001	0.998	0.000
M01.40 Rubella arthritis (Multiple sites)	0.001	0.998	0.000
M01.59 Arthritis in other viral diseases classified elsewhere (Site unspecified)	0.001	0.998	0.000
M01.58 Arthritis in other viral diseases classified elsewhere (Other)	0.001	0.998	0.000
M01.57 Arthritis in other viral diseases classified elsewhere (Ankle and foot)	0.001	0.998	0.000
M01.56 Arthritis in other viral diseases classified elsewhere (Lower leg)	0.001	0.998	0.000
M01.55 Arthritis in other viral diseases classified elsewhere (Pelvic region and thigh)	0.001	0.998	0.000
M01.54 Arthritis in other viral diseases classified elsewhere (Hand)	0.001	0.998	0.000
M01.53 Arthritis in other viral diseases classified elsewhere (Forearm)	0.001	0.998	0.000
M01.52 Arthritis in other viral diseases classified elsewhere (Upper arm)	0.001	0.998	0.000
M01.51 Arthritis in other viral diseases classified elsewhere (Shoulder region)	0.001	0.998	0.000
M01.50 Arthritis in other viral diseases classified elsewhere (Multiple sites)	0.001	0.998	0.000
M01.69 Arthritis in mycoses (Site unspecified)	0.001	0.998	0.000
M01.68 Arthritis in mycoses (Other)	0.001	0.998	0.000
M01.67 Arthritis in mycoses (Ankle and foot)	0.001	0.998	0.000
M01.66 Arthritis in mycoses (Lower leg)	0.001	0.998	0.000
M01.65 Arthritis in mycoses (Pelvic region and thigh)	0.001	0.998	0.000
M01.64 Arthritis in mycoses (Hand)	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations